Dermira Added to NASDAQ Biotechnology Index
December 15, 2015 07:00 ET
|
Dermira, Inc.
MENLO PARK, Calif., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to...
Dermira Reports Third Quarter 2015 Financial Results and Provides Corporate Update
November 10, 2015 16:24 ET
|
Dermira, Inc.
MENLO PARK, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Completes Patient Enrollment for First CIMZIA(R) (Certolizumab Pegol) Phase 3 Clinical Trial in Psoriasis Program
October 12, 2015 16:21 ET
|
Dermira, Inc.
MENLO PARK, Calif., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Elects Kathleen Sebelius to Board of Directors
September 30, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Present Data for DRM01 Acne Program at EADV Congress 2015
September 29, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Sept. 29, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Skin Disposition Study Results for Dermira's DRM01 Program in Acne Presented at International Dermatology Meeting
September 10, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR Meeting
September 03, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Second Quarter 2015 Financial Results and Provides Corporate Update
August 13, 2015 16:15 ET
|
Dermira, Inc.
Two Product Candidates Now in Phase 3 Development
Approximately $104 Million in Net Proceeds From Recent Follow-on Public Offering
MENLO PARK, Calif., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Dermira,...
Dermira Announces Closing of Follow-on Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
August 11, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Prices Follow-On Public Offering of Common Stock
August 05, 2015 20:29 ET
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...